查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2085712

基因檢測市場：2026-2032年全球市場預測（按服務類型、檢測類型、技術、檢體類型、應用、最終用戶和分銷管道分類）

Genetic Testing Market by Offering, Test Type, Technology, Sample Type, Application, End-User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，基因檢測市場將成長至 397.2 億美元，複合年成長率為 14.44%。

主要市場統計數據
基準年 2025 154.4億美元
預計年份：2026年 176億美元
預測年份 2032 397.2億美元
複合年成長率 (%) 14.44%

基因檢測市場簡介

隨著次世代定序、基於PCR的檢測、微陣列和標靶基因檢測等技術在疾病早期檢測、精準醫療、帶因者篩檢、藥物基因體學和腫瘤伴隨診斷等領域的應用，基因檢測市場正從小眾診斷領域轉向主流醫療領域。美國國家人類基因組研究所（NHGRI）報告稱，自人類基因組計畫啟動以來，定序成本已大幅下降，這使得基因組檢測能夠在醫院、實驗室和直接面對消費者的銷售管道中得到更廣泛的臨床應用。

基因檢測領域的變革性變化

該領域的格局正因從單基因檢測到多基因panel、全外EXOME定序和全基因測序的轉變而改變。腫瘤學仍然是該領域的核心成長引擎，因為腫瘤譜分析和種系檢測指南標靶治療和免疫療法的適應症確定，以及遺傳性癌症風險的管理。美國食品藥物管理局（FDA）批准使用次世代定序的伴隨診斷，進一步鞏固了基因組證據在藥物選擇中的作用。

人工智慧對基因檢測的累積影響

人工智慧 (AI) 透過改進變異識別、註釋、表現型匹配、檢查室工作流程自動化和臨床報告生成，正在加速基因檢測的發展。 AI 驅動的生物資訊學可以幫助優先識別意義不明的變異，並將基因組觀察與 ClinVar 等精心整理的資料庫進行匹配，從而支持在罕見疾病和腫瘤學領域更有效率地解讀結果。

基因檢測的關鍵區域趨勢

北美在臨床應用方面處於領先地位，這得益於其完善的參考實驗室、腫瘤檢測基礎設施、FDA批准的基因組診斷、CLIA監管的檢測流程、NIH支持的基因組研究，以及針對某些遺傳性癌症、產前檢測、罕見疾病和腫瘤譜分析的保險覆蓋。在歐洲，各國基因組計畫、NHS基因組醫療服務、法國基因組醫學舉措、德國精準腫瘤學活動以及GDPR下強力的資料保護措施正在主導相關領域的發展，同時歐盟的體外醫療設備法規（IVDR）也在提高體外診斷醫療設備的合規標準。

全球基因檢測市場關鍵群體分析

這些技術的應用在東南亞國協呈現多樣化的趨勢。新加坡正大力推動先進的基因組醫學、精準醫學和生物醫學研究，而鄰國則隨著醫療保健投資的增加，正在擴大產前檢測、腫瘤學和感染疾病相關分子診斷的覆蓋範圍。在海灣合作理事會（GCC）國家，阿拉伯聯合大公國、卡達和沙烏地阿拉伯等國在政府主導的精準醫學策略的支持下，正優先進行大規模人群基因組計畫、婚前篩檢、新生兒篩檢和遺傳疾病檢測。

主要國家基因檢測趨勢

美國仍然是最大的創新中心，這得益於其龐大的臨床實驗室、癌症中心、美國國立衛生研究院 (NIH) 資助的基因組研究、CLIA（臨床實驗室改進法案）下的檢查室法規以及 FDA 對伴隨診斷的監管。加拿大則專注於公共資助的食品藥物管理局整合、省級醫保覆蓋範圍決策、新生兒篩檢和癌症遺傳學項目，而墨西哥則在私營部門的基因檢測和腫瘤診斷方面取得了長足發展。巴西在拉丁美洲的精準醫療領域處於領先地位，尤其是在遺傳性癌症、生殖遺傳學和產前檢測方面。

為基因檢測領域的領導者提供的實用建議

產業領導者應優先考慮在腫瘤學、遺傳性癌症、罕見疾病、生殖醫學、新生兒篩檢和藥物基因組學等高價值領域開展經臨床檢驗且符合指南的檢測。透過真實世界結果、衛生經濟學、分析有效性檢驗和臨床效用研究來建立保險公司認可的證據，對於擴大保險覆蓋範圍和促進醫生採納至關重要。

調查方法

本執行摘要採用符合既定產業研究標準的二手調查方法編寫，並參考了監管出版刊物、公共衛生機構、同行評審文獻、臨床指南制定機構、國家基因組計畫和經認可的醫療資訊揭露資料等檢驗資訊來源。市場分析重點在於基因檢測普及的促進因素、保險報銷趨勢、監管變化和技術發展。

結論

基因檢測正成為精準醫療的基石，透過檢驗的基因組訊息，改善診斷、預防、治療選擇、生育計畫和家族風險評估。定序成本的降低、臨床證據的增強、在腫瘤學領域應用的增加以及數位生物資訊學的發展，正推動基因檢測從專業應用領域走向常規醫療保健。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 基因檢測市場：依產品/服務分類

  • 裝置
    • 序列器
    • PCR系統
    • 微陣列掃描儀
  • 軟體和資訊技術
    • 突變解讀
    • 臨床決策支持
    • 生物資訊學
  • 服務
    • 諮詢
    • 維護和支援
  • 試劑和耗材

第8章 基因檢測市場：依檢測類型分類

  • 基因帶原檢測
  • 診斷測試
  • 新生兒篩檢
  • 藥物基因體學
  • 胚胎著床前檢測
  • 產前檢查
  • 症狀前和預測性測試

第9章 基因檢測市場：依技術分類

  • 細胞遺傳學
  • DNA定序
  • 基因表現分析
  • 微陣列
  • 聚合酵素鏈鎖反應（PCR）

第10章 基因檢測市場：依樣本類型分類

  • 血
  • 唾液
  • 組織
  • 口腔黏膜拭子

第11章：基因檢測市場：依應用領域分類

  • 自體免疫疾病
  • 腫瘤學
  • 慢性病
  • 遺傳性疾病
  • 神經退化性疾病

第12章 基因檢測市場：依最終用戶分類

  • 診斷檢查室
  • 家庭環境
  • 醫院和診所

第13章 基因檢測市場：依通路分類

  • 離線
  • 線上

第14章 基因檢測市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第15章 基因檢測市場：依群體分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 基因檢測市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • BGI Genomics
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Bruker Corporation
  • CooperSurgical Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • GeneDx, LLC
  • Guardant Health Inc.
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • Newtopia Inc.
  • PathogenDx Corporation
  • PerkinElmer Inc.
  • Qiagen NV
  • Quest Diagnostics Incorporated
  • Revvity Inc.
  • Sanofi SA
  • Sonic Healthcare
  • Tempus AI, Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-437E9896A512

The Genetic Testing Market is projected to grow by USD 39.72 billion at a CAGR of 14.44% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 15.44 billion
Estimated Year [2026] USD 17.60 billion
Forecast Year [2032] USD 39.72 billion
CAGR (%) 14.44%

Genetic Testing Market Introduction

The genetic testing market is moving from specialized diagnostics into mainstream healthcare as next-generation sequencing, PCR-based assays, microarrays, and targeted panels support earlier disease detection, precision medicine, carrier screening, pharmacogenomics, and oncology companion diagnostics. The National Human Genome Research Institute has documented a dramatic decline in sequencing costs since the Human Genome Project, enabling broader clinical use of genomic testing across hospitals, reference laboratories, and direct-to-consumer channels.

Demand is being reinforced by the rising burden of cancer, rare diseases, inherited cardiovascular conditions, reproductive health needs, and medication-response variability. Clinically validated genetic tests are increasingly embedded in care pathways, while regulators, payers, and health systems are emphasizing analytical validity, clinical validity, informed consent, data privacy, and equitable access.

Transformative Shifts in the Genetic Testing Landscape

The landscape is being reshaped by the shift from single-gene testing to multi-gene panels, whole-exome sequencing, and whole-genome sequencing. Oncology remains a central growth engine as tumor profiling and germline testing guide targeted therapies, immunotherapy eligibility, and hereditary cancer risk management. The U.S. FDA's authorization of next-generation sequencing companion diagnostics has helped normalize genomic evidence in drug selection.

At the same time, reproductive genetics, non-invasive prenatal screening, newborn sequencing research, and pharmacogenomics are expanding the clinical scope of genetic testing. The market is also adapting to stricter oversight, including the EU In Vitro Diagnostic Regulation and ongoing scrutiny of laboratory-developed tests, which is pushing providers toward stronger quality systems, post-market evidence, and transparent clinical utility documentation.

Cumulative Impact of Artificial Intelligence on Genetic Testing

Artificial intelligence is accelerating genetic testing by improving variant calling, annotation, phenotype matching, laboratory workflow automation, and clinical report generation. AI-enabled bioinformatics can help prioritize variants of uncertain significance, cross-reference genomic findings with curated databases such as ClinVar, and support more efficient interpretation in rare disease and oncology settings.

The impact is cumulative rather than isolated: better algorithms increase throughput, richer datasets improve model performance, and digital reporting strengthens clinician adoption. However, responsible deployment requires explainability, validation across diverse populations, bias monitoring, cybersecurity, human expert review, and compliance with privacy frameworks such as HIPAA, GDPR, and relevant national genomics regulations.

Key Regional Insights for Genetic Testing

North America leads in clinical adoption due to established reference laboratories, oncology testing infrastructure, FDA-cleared genomic diagnostics, CLIA-regulated laboratory practices, NIH-supported genomics research, and payer coverage for selected hereditary cancer, prenatal, rare disease, and tumor profiling tests. Europe is advancing through national genomics programs, the NHS Genomic Medicine Service, France's genomic medicine initiatives, Germany's precision oncology activity, and strong data protection under GDPR, while the EU IVDR is raising the compliance threshold for in vitro diagnostics.

Asia-Pacific is scaling rapidly as Japan, China, South Korea, India, and Australia expand precision medicine, population genomics, newborn and rare disease initiatives, and cancer testing capacity. Latin America, led by Brazil and Mexico, is increasing access through private laboratories, academic hospitals, and oncology centers, though reimbursement and specialist availability remain uneven. The Middle East is notable for national genome programs and premarital screening policies in the GCC, while Africa is building genomic capacity through research networks, infectious disease sequencing, and public health genomics initiatives despite infrastructure, workforce, and funding constraints.

Key Group Insights Across Global Genetic Testing Markets

ASEAN presents a diverse adoption profile, with Singapore supporting advanced genomics, precision medicine, and biomedical research while neighboring markets expand prenatal, oncology, and infectious disease-related molecular diagnostics as healthcare investment rises. The GCC is prioritizing population-scale genome programs, premarital screening, newborn screening, and inherited disease detection, supported by government-led precision medicine strategies in the United Arab Emirates, Qatar, and Saudi Arabia.

The European Union is defined by harmonized data protection under GDPR, increasing diagnostic regulation under IVDR, national genomic medicine investments, and cross-border research collaboration. BRICS countries offer scale through large populations, national genomics initiatives, and growing local sequencing capacity, although reimbursement, laboratory accreditation, and data governance vary. G7 countries remain influential in clinical standards, reimbursement evidence, rare disease policy, and guideline development, while NATO members create demand around secure health data infrastructure, biosecurity readiness, resilient diagnostics supply chains, and interoperable laboratory systems.

Key Country Insights for Genetic Testing

The United States remains the largest innovation hub, supported by major clinical laboratories, cancer centers, NIH-funded genomics research, CLIA laboratory regulation, and FDA oversight of companion diagnostics. Canada emphasizes publicly funded healthcare integration, provincial coverage decisions, newborn screening, and cancer genetics programs, while Mexico is expanding private-sector genetic testing and oncology diagnostics. Brazil leads much of Latin America's precision medicine activity, especially in hereditary cancer, reproductive genetics, and prenatal testing.

The United Kingdom benefits from the NHS Genomic Medicine Service and lessons from the 100,000 Genomes Project. Germany, France, Italy, and Spain are advancing genomic medicine through national and regional programs, oncology networks, and rare disease initiatives, while Russia maintains interest in genetics research and domestic testing capacity. China is advancing population genomics, oncology testing, and sequencing infrastructure; India is expanding genetic testing for rare diseases, reproductive health, and cancer through major urban centers; Japan combines precision oncology, pharmacogenomics, and aging-related healthcare priorities; Australia supports clinical genomics through national research and healthcare initiatives; and South Korea is strengthening cancer profiling, clinical sequencing, and digital health integration.

Actionable Recommendations for Genetic Testing Leaders

Industry leaders should prioritize clinically validated, guideline-aligned tests in high-value areas such as oncology, hereditary cancer, rare disease, reproductive health, newborn screening, and pharmacogenomics. Building payer-ready evidence through real-world outcomes, health economics, analytical validation, and clinical utility studies is essential for broader reimbursement and physician adoption.

Organizations should also invest in AI-enabled bioinformatics, interoperable reporting, genetic counseling support, secure cloud infrastructure, and laboratory quality management while maintaining rigorous compliance standards. Partnerships with hospitals, pharmaceutical developers, population genomics programs, public health agencies, and academic centers can accelerate data access and validation. To improve equity, leaders should expand reference datasets beyond European ancestry, strengthen informed consent processes, and design affordable testing models for underserved populations.

Research Methodology

This executive summary is developed using a secondary research methodology aligned with established industry research standards, drawing on verified sources such as regulatory publications, public health agencies, peer-reviewed literature, clinical guideline bodies, national genomics programs, and recognized healthcare disclosures. Market interpretation emphasizes documented adoption drivers, reimbursement trends, regulatory changes, and technology developments in genetic testing.

The analysis triangulates evidence across clinical application areas, technology platforms, end-user demand, regional policy environments, and competitive activity. Findings are validated by comparing information from multiple credible sources and excluding unsupported claims, market sizing, market share, or forecasting. The methodology prioritizes analytical validity, clinical utility, regulatory relevance, data governance, and measurable healthcare impact.

Conclusion

Genetic testing is becoming a foundational pillar of precision healthcare, with validated genomic insights improving diagnosis, prevention, treatment selection, reproductive planning, and family risk assessment. Falling sequencing costs, stronger clinical evidence, expanded oncology use, and digital bioinformatics are pushing genetic testing from specialized use toward routine care.

Future progress will depend on reimbursement clarity, ethical data governance, clinician education, genetic counseling capacity, diverse genomic datasets, and scalable laboratory quality. Organizations that combine scientific rigor with accessible delivery models, AI-enabled interpretation, and privacy-first infrastructure will be best positioned to lead the next phase of the global genetic testing market.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Genetic Testing Market, by Offering

  • 7.1. Instruments
    • 7.1.1. Sequencers
    • 7.1.2. PCR Systems
    • 7.1.3. Microarray Scanners
  • 7.2. Software & Informatics
    • 7.2.1. Variant interpretation
    • 7.2.2. Clinical decision support
    • 7.2.3. Bioinformatics
  • 7.3. Services
    • 7.3.1. Consulting
    • 7.3.2. Maintenance & Support
  • 7.4. Reagents & Consumables

8. Genetic Testing Market, by Test Type

  • 8.1. Carrier Testing
  • 8.2. Diagnostic Testing
  • 8.3. New Born Screening
  • 8.4. Pharmacogenomics
  • 8.5. Preimplantation Testing
  • 8.6. Prenatal Testing
  • 8.7. Presymptomatic & Predictive Testing

9. Genetic Testing Market, by Technology

  • 9.1. Cytogenetics
  • 9.2. DNA Sequencing
  • 9.3. Gene Expression Profiling
  • 9.4. Microarrays
  • 9.5. Polymerase Chain Reaction (PCR)

10. Genetic Testing Market, by Sample Type

  • 10.1. Blood
  • 10.2. Saliva
  • 10.3. Tissue
  • 10.4. Buccal swab

11. Genetic Testing Market, by Application

  • 11.1. Autoimmune Disorders
  • 11.2. Oncology
  • 11.3. Chronic Diseases
  • 11.4. Genetic Disorders
  • 11.5. Neurodegenerative Diseases

12. Genetic Testing Market, by End-User

  • 12.1. Diagnostic Laboratories
  • 12.2. Home Setting
  • 12.3. Hospitals & Clinics

13. Genetic Testing Market, by Distribution Channel

  • 13.1. Offline
  • 13.2. Online

14. Genetic Testing Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. North America
  • 14.3. Latin America
  • 14.4. Europe
  • 14.5. Middle East
  • 14.6. Africa

15. Genetic Testing Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Genetic Testing Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. Abbott Laboratories
  • 18.2. Agilent Technologies, Inc.
  • 18.3. Becton, Dickinson and Company
  • 18.4. BGI Genomics
  • 18.5. Bio-Rad Laboratories, Inc.
  • 18.6. Bio-Techne Corporation
  • 18.7. Bruker Corporation
  • 18.8. CooperSurgical Inc.
  • 18.9. Eurofins Scientific SE
  • 18.10. F. Hoffmann-La Roche AG
  • 18.11. GeneDx, LLC
  • 18.12. Guardant Health Inc.
  • 18.13. Illumina, Inc.
  • 18.14. Invitae Corporation
  • 18.15. Laboratory Corporation of America Holdings
  • 18.16. Myriad Genetics, Inc.
  • 18.17. Natera, Inc.
  • 18.18. Newtopia Inc.
  • 18.19. PathogenDx Corporation
  • 18.20. PerkinElmer Inc.
  • 18.21. Qiagen N.V.
  • 18.22. Quest Diagnostics Incorporated
  • 18.23. Revvity Inc.
  • 18.24. Sanofi S.A.
  • 18.25. Sonic Healthcare
  • 18.26. Tempus AI, Inc.
  • 18.27. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GENETIC TESTING MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL GENETIC TESTING MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL GENETIC TESTING MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL GENETIC TESTING MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL GENETIC TESTING MARKET SIZE, BY OFFERING, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL GENETIC TESTING MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SEQUENCERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SEQUENCERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SEQUENCERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PCR SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PCR SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PCR SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MICROARRAY SCANNERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MICROARRAY SCANNERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MICROARRAY SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SOFTWARE & INFORMATICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SOFTWARE & INFORMATICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SOFTWARE & INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VARIANT INTERPRETATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VARIANT INTERPRETATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VARIANT INTERPRETATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL DECISION SUPPORT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL DECISION SUPPORT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL DECISION SUPPORT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIOINFORMATICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOINFORMATICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CONSULTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CONSULTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CONSULTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CARRIER TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CARRIER TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CARRIER TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DIAGNOSTIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DIAGNOSTIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEW BORN SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEW BORN SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NEW BORN SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PREIMPLANTATION TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PREIMPLANTATION TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PREIMPLANTATION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PRENATAL TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PRENATAL TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PRESYMPTOMATIC & PREDICTIVE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PRESYMPTOMATIC & PREDICTIVE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PRESYMPTOMATIC & PREDICTIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CYTOGENETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CYTOGENETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CYTOGENETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DNA SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DNA SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DNA SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GENE EXPRESSION PROFILING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GENE EXPRESSION PROFILING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GENE EXPRESSION PROFILING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MICROARRAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MICROARRAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MICROARRAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SALIVA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SALIVA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SALIVA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL TISSUE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL TISSUE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL TISSUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BUCCAL SWAB MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BUCCAL SWAB MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BUCCAL SWAB MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL AUTOIMMUNE DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL AUTOIMMUNE DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL AUTOIMMUNE DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CHRONIC DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CHRONIC DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CHRONIC DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL GENETIC DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL GENETIC DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL GENETIC DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEURODEGENERATIVE DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL NEURODEGENERATIVE DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL NEURODEGENERATIVE DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL HOME SETTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL HOME SETTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL HOME SETTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE GENETIC TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA GENETIC TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN GENETIC TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. GCC GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. GCC GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 204. GCC GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 205. GCC GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 206. GCC GENETIC TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 207. GCC GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. GCC GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. GCC GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. GCC GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. GCC GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 212. GCC GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS GENETIC TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 235. G7 GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. G7 GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 237. G7 GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 238. G7 GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 239. G7 GENETIC TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 240. G7 GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. G7 GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 242. G7 GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. G7 GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. G7 GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 245. G7 GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. NATO GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. NATO GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 248. NATO GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 249. NATO GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 250. NATO GENETIC TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 251. NATO GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. NATO GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. NATO GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. NATO GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. NATO GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 256. NATO GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 257. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES GENETIC TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 269. CANADA GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. CANADA GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 271. CANADA GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 272. CANADA GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 273. CANADA GENETIC TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 274. CANADA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. CANADA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 276. CANADA GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. CANADA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. CANADA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 279. CANADA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 280. MEXICO GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 281. MEXICO GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 282. MEXICO GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 283. MEXICO GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 284. MEXICO GENETIC TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 285. MEXICO GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. MEXICO GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 287. MEXICO GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. MEXICO GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 289. MEXICO GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 290. MEXICO GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 291. BRAZIL GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 292. BRAZIL GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 293. BRAZIL GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 294. BRAZIL GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 295. BRAZIL GENETIC TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 296. BRAZIL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. BRAZIL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 298. BRAZIL GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. BRAZIL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 300. BRAZIL GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 301. BRAZIL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 302. UNITED KINGDOM GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 303. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 313. GERMANY GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 314. GERMANY GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 315. GERMANY GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 316. GERMANY GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 317. GERMANY GENETIC TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 318. GERMANY GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. GERMANY GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 320. GERMANY GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 321. GERMANY GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 322. GERMANY GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 323. GERMANY GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 324. FRANCE GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 325. FRANCE GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 326. FRANCE GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 327. FRANCE GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 328. FRANCE GENETIC TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 329. FRANCE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 330. FRANCE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 331. FRANCE GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. FRANCE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 333. FRANCE GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 334. FRANCE GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 335. RUSSIA GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 336. RUSSIA GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 337. RUSSIA GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 338. RUSSIA GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 339. RUSSIA GENETIC TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 340. RUSSIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 341. RUSSIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 342. RUSSIA GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 343. RUSSIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 344. RUSSIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 345. RUSSIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 346. ITALY GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 347. ITALY GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 348. ITALY GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 349. ITALY GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 350. ITALY GENETIC TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 351. ITALY GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 352. ITALY GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 353. ITALY GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 354. ITALY GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 355. ITALY GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 356. ITALY GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 357. SPAIN GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 358. SPAIN GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 359. SPAIN GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 360. SPAIN GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 361. SPAIN GENETIC TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 362. SPAIN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 363. SPAIN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 364. SPAIN GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 365. SPAIN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 366. SPAIN GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 367. SPAIN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 368. CHINA GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 369. CHINA GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 370. CHINA GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 371. CHINA GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 372. CHINA GENETIC TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 373. CHINA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 374. CHINA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 375. CHINA GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 376. CHINA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 377. CHINA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 378. CHINA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 379. INDIA GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 380. INDIA GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 381. INDIA GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 382. INDIA GENETIC